top of page

Search Results

Search this site

Results found for empty search

  • Courses (List) | Acn Home

    Autism Community Network Annual Fall Summit Toward Neuroharmony: Welcome to the Autism Renaissance Keynote Speaker: Elizabeth Torres, PhD Plenary Speaker: Rosemary White, OTR/L Friday, October 2, 2026 ACN 2026 Summit Conference Day Location: Tobin Center for the Performing Arts: 100 Auditorium Cir, San Antonio, TX 78205 7:30 AM - 4:30 PM Saturday, October 3, 2026 Clinical Intensive Training Day Location: Autism Community Network: 535 Bandera Rd. San Antonio, TX 78228 8:15 AM - 4:30 PM Click here to learn more about Clinical Intensive Keynote: Elizabeth Torres, PhD Clinical Scholar, Neurodiversity Ally, and Head of the Rutger's University Sensory-Motor Integration Lab Please find more information on Dr. Torres and ACN Summit 2026, Toward Neuroharmony below. To register for the event, click below. REGISTER Agenda 7:30 - 8:15 AM Registration, Breakfast, and Resource Fair 8:15 - 9:45 AM Keynote Address 10:00 - 11:15 AM Morning Breakout Sessions Caregiver, Educator, and Clinician Tracks 11:30 - 12:30 PM Lunch & Learn: Experts by Experience Panel 12:45 - 1:30 PM Second Keynote Address 1:40 - 2:40 PM Plenary Address 2:45 - 4:00 PM The Every Voice Matters Panel 4:00 - 4:30 PM Closing Ceremony Summit Sessions. KEYNOTE ADDRESS: Autism: The Movement Sensing Perspective Time Presenter/Facilitator 8:15-9:45 AM Elizabeth Torres, PhD Outcomes & Disclosures Caregiver Track: AM Breakout Session Listening Differently: How to Honor Your Autistic Child’s Brilliance, Autonomy, and Voice Time Presenter/Facilitator 10:00-11:15 AM Tiffany Hammond Outcomes & Disclosures Educator Track: AM Breakout Session: Brains, Behavior, and Belonging Time Presenter/Facilitator 10:00-11:15 AM Rebecca Engle, MEd Outcomes & Disclosures Clinician Track: AM Breakout Session: The Movement Sensing Perspective UNPACKED Time Presenter/Facilitator 10:00-11:15 AM Rosemary White, OTR/L Outcomes & Disclosures Expertise by Experience: Amplifying Autistic Voices Panel Time Presenter/Facilitator Lunch & Learn - 11:30 AM-12:30 PM TBD Outcomes & Disclosures Second Keynote Address: Autism Autonomy: In Search of our Human Dignity Time Presenter/Facilitator 12:45-1:30 PM Elizabeth Torres, PhD Outcomes & Disclosures Plenary Address: Supporting Individual Differences While Promoting Relationships through DIR®/Floortime Time Presenter/Facilitator 1:40 - 2:40 PM Rosemary White, OTR/L Outcomes & Disclosures The "Every Voice Matters" Panel Time Presenter/Facilitator 2:45-4:00 PM Dr. Carrie Alvarado, PhD, OTR Outcomes & Disclosures Clinical Intensive Day -Additional Day of training for Professionals only 10/3/2026- At Autism Community Network Time Presenter/Facilitator 8:00 AM - 4:30 PM Dr. Elizabeth Torres and Rosemary White, OTR/L Outcomes & Disclosures PENDING APPROVAL Autism Community Network is a registered CPE provider for the Texas Education Agency. ASHA CE Provider approval and use of the Brand Block does not imply endorsement of course content, specific products, or clinical procedures This program is designed to meet BHEC continuing education requirements for Texas behavioral health professionals. Fees. Availability based on venue capacity. Packages are sold on a first come first served basis. Early Bird Registration (June 12 - August 16) $125 Regular Registration (August 4 - September 30) $150 Late Registration (October 1-2) $175 Caregivers / Adult Autists Scholarships Available $100 Group Rate/Students Email Carrie@acn-sa.org Conference and Clinical Intensive Bundle (10/2 & 10/3) - $200 Clinical Intensive Day only (10/3) - $125 ACN Clinical Intensive Day - 10/3/2026 Learn more about our Clinical Intensive Day Polices & Procedures. Accommodations Search Find the full policy here. We strive to create a conference experience that is accessible to all. Our goal is to identify and address any barriers that may prevent full participation, in compliance with the Americans with Disabilities Act (ADA) and other relevant legislation. Refunds Search Find the full policy here. We understand that circumstances may change, and you may need to cancel your registration for our conference. Our refund policy is designed to be fair and transparent, ensuring that attendees can plan with confidence. Complaint Policy Search Find the full policy here. We are dedicated to maintaining a high standard of service and support. We encourage attendees to provide feedback and report any concerns or complaints. All complaints will be treated with respect and confidentiality. Sponsors Sponsorship Opportunities Search For more information on sponsorship opportunities, please email Cortney@acn-sa.org For more information on becoming a vendor/exhibitor, please email Carrie@acn-sa.org Star Additional Information. For questions related to credentialing information and receiving CEUs, scholarships, or any other information not included on this page or the registration website, please reach out to Carrie@acn-sa.org .

  • News Grid | Acn Home

    In the news. Get the latest in autism news here. Apr 20, 2024 Spurs coach Gregg Popovich's support of autism acceptance reached global audience His inclusive message about the need not to treat autistic people as the "other" touched those with the disability and their advocates. Read More Apr 2, 2024 SAPD cadets learn how to respond to incidents involving people with autism San Antonio nonprofits have teamed up to create a training program to help San Antonio police cadets better understand autism spectrum disorders. Read More Feb 4, 2024 LOCAL Closer Look: Autism Community Network Felipe Aguilar talks with Adrienne Gaither, Director of Caregiver Empowerment and Occupational Therapist, Autism Community Network (ACN) in San Antonio. Read More Dec 20, 2023 Sound and vision: How San Antonio is building inclusivity in arts and culture Sensory-friendly events are primarily designed to accommodate those with autism spectrum disorder who might have difficulties adjusting behaviors to social situations or communicating their needs effectively. Read More Aug 28, 2023 'Emergent and transactional': How Jonathan Green is Rethinking Autism and Interventions Jonathan Green is professor of child and adolescent psychiatry at the University of Manchester in the United Kingdom and an honorary consultant child and adolescent psychiatrist. He is also a long-practicing clinician. In this interview, he discusses the genesis of his recent article, “Debate: Neurodiversity, autism and healthcare,” and how it has been received by colleagues and the neurodiversity self-advocate community. There have been two commentaries published in response to Green’s article, with a third still in production. Read More Mar 27, 2023 Pediatric Autism Communication Therapy Improved Long-Term Child Outcomes Pediatric Autism Communication Therapy is currently the only scientifically evidenced early social communication intervention to demonstrate long-term improved child social communication outcomes into middle childhood. Read More Jun 18, 2022 We Should Tell Children They Are Autistic As Soon As Possible Many parents in our community feel they don’t know the “right” way or time to tell autistic children about their autism. For this reason, we are grateful for a recent study showing that “it is probably best to tell people they are autistic as soon as possible.” We talked with Bella Kofner, an author on the study who is also autistic, about what the study reveals; the personal experience of being told about one’s own autism; why it is crucial for autism research to include autistic direction; and some takeaways for both parents and/or autistic people themselves. Read More

  • Team1

    Who we are. At Autism Community Network, we are passionate about empowering families and caregivers to be the principal advocates, caregivers, and champions in their children’s lives. Our mission is to provide support, education and resources to those affected by autism. We strive to make a difference in the lives of autistic individuals and their families by providing educational resources, support groups, and community events. Our goal is to ensure that those affected by autism get the support and resources they need to lead a successful life. Our organization. Autism Community Network (ACN) was established as a 501(c)(3) in 2008 by a consortium of health care funders concerned about the lack of child development services available to children suspected of having autism spectrum disorder (ASD). This initiative was led by Palmer Moe, former executive manager of the Kronkosky Charitable Foundation. ACN addresses the diagnostic, therapeutic, educational, and recreational needs of families impacted by autism living in South Texas. Our mission. Our mission is to maximize the potential of children with autism by providing early diagnosis for those with limited access and educating and empowering the community to support them. Elephant-sized values. You may have noticed our larger-than-life mascot. As an autism nonprofit dedicated to forming relationships and nurturing the wellness of the autism ecosystem, we thought of nothing more fitting than the elephant. Elephants live in tightly bonded herds, also known as “packs” or “parades.” The herd, led by the oldest and largest matriarch, can consist of up to 100 individual elephants. Known for their high intellect and ability to store memories, elephants have been observed to display signs of emotions such as playfulness, joy, anger, and grief. These beautiful giants communicate through subsonic rumbles, which travel through the earth under their feet more quickly than through the air above them. Interestingly, elephants receive the rumbling messages through the skin on their feet and trunks, indicating highly attuned sensory systems. When a baby calf is born, the entire herd helps to raise and protect their young. ACN believes our commitment to holistic community support mirrors this natural phenomenon, and we are happy to take cues from our mammalian friends! Read More Team Our team. Tiffany Fresher Chief Executive Officer Read More Adrienne Gaither, OTR, CSIPT, C/NDT Chief Programs Officer & Occupational Therapist Read More Teresa Camacho Medical Billing Manager Read More Gabriel Gonzalez, OTD, OTR/L Bilingual Occupational Therapist Read More Jarrod Purkeypile, MA CCC-SLP Speech Language Pathologist Read More Angela Sanchez-Concha Caregiver Coordinator Read More Carrie Alvarado, PhD, OTR Chief Operating Officer Read More Cortney John, MA Chief Development & Outreach Officer Read More Casey Garza, MPA Community Engagement Coordinator Read More Cathy Kersey Accounting Manager Read More Arjai Ramos Front Desk Coordinator Read More Anna Paola Smith, LCSW Licensed Clinical Social Worker Read More Alma Patricia del Angel, MD Chief Medical Officer & Developmental Behavioral Pediatrician Read More Vanessa Amaya Referral Coordinator Read More Noelia Cheatham Billing Specialist Read More Lisa Martinez-Jimenez Board Certified Behavior Analyst Read More Nicolle Reyna, MS CCC-SLP Speech Language Pathologist Read More Reach out. Each family's journey with autism is AUsomely unique. Let our staff walk beside you on your pathway. Start Now Our board of directors. OFFICERS Joshua Behnke - President Behnke Legal Consulting, PLLC Denise Garcia - Vice President Texas Partners Bank Matthew Occhipinti - Treasurer Northwestern Mutual Greg Hanson, DO, FAAP - Secretary Southwest Children's Cente r MEMBERS Wendy Faldet HEB Beth Jones Assistant Superintendent - SAISD Manny Nsien President and CEO of Superior Living Foundation Ursula Pari Former KSAT 12 News Anchor & CEO of San Antonio Polo Club Michael Thompson Merrill Lynch Kristen Williams, PhD Executive Director of Disability Services - SAISD, Retired Ashley Yarborough Advocate/Sibling Bobby Sims Jr. HEB – Senior Facility Leader of Super Regional (Dry Grocery) Neurodiversity-Affirming Practice Advisory Committee. We're excited to introduce our Neurodiversity-Affirming Practice Advisory Committee. This committee, including neurodiverse individuals of all stripes, serves to provide our board and our staff with ongoing guidance and support from a position of lived experience to assure our consistent alignment with strengths-based and neurodiversity-affirming practice.

  • Adrienne Gaither, OTR, CSIPT, C/NDT

    < Back Adrienne Gaither, OTR, CSIPT, C/NDT Chief Programs Officer & Occupational Therapist Adrienne Gaither has been a pediatric occupational therapist for over 25 years. She received her degree from The University of Texas Health Science Center at San Antonio and began her pediatric therapy career, eventually gaining experience in every setting available for the provision of children’s Occupational Therapy services. Adrienne has had the opportunity to serve as a member of ACN’s team since 2009. She is a Pediatric Autism Communication Therapy Accredited Practitioner, supporting families impacted by autism through dyadic coaching and a part of ACN’s interdisciplinary diagnostic team that uses a strength-based, neurodiversity-affirming approach to address the unique presentation of the child and family. Adrienne also holds specialty pediatric certification in the Sensory Integration and Praxis Tests (SIPT) and has completed advanced training in Neurodevelopmental Treatment (NDT) for children. Locally, Adrienne had the privilege of serving on the planning team for the development of Morgan’s Wonderland; in particular, contributing recommendations for the Sensory Village portion of the park. In addition to her work with ACN, Adrienne is a part-time Program Director and Sensory Consultant with Kinetic Kids, Inc., a local non-profit agency providing sports and recreation activities for children and teenagers with special needs. When she is not working, Adrienne enjoys life with her husband, 2 children, and 2 dogs, running, singing, and traveling. adrienne@acn-sa.org (210) 435-1000

  • FUNDING & MEDICAID WAIVERS | Acn Home

    < Back FUNDING & MEDICAID WAIVERS About Waiver Services Our funding and Medicaid waiver resources provide information on funding and support programs available to individuals with autism and their families. These resources can help families access financial support for necessary services and supports. FUNDING & MEDICAID WAIVERS AACOG, Alamo Local Authority for IDD 210.832.5020 Web: https://www.aacog.com/IDDServices 8700 Tesoro Dr., Ste. 160, SA TX 78217 Provides Eligibility Determination (autism is a related condition), service coordination for General Revenue Services and Texas Home Living program, enrollment into the Home and Community-Based services program, In-Home Family Support Program and admissions into Intermediate Care Facilities-MR and State Schools Bluebonnet Trails Community Services 844.309.6385 Web: https://bbtrails.org/autism/ 1009 North Georgetown St., Round Rock, Texas 78664 A family-centered approach to teaching individuals’ skills necessary to succeed in the home, school and community (Bastrop, Burnet, Caldwell, Fayette, Gonzales, Guadalupe, Hays, Lee, Travis, and Williamson counties). Camino Real Community Services 210.357.0300 Web: www.caminorealcs.org P.O. Box 725, Lytle, TX 78052 Early Childhood Intervention Services, Mental Health Services, Intellectual & Developmental Disability Services. Community Living Assistance and Support Services (CLASS) 877.438.5658 Web: Click Here Provides home- and community-based services such as respite care, nursing services, adaptive aids/supplies, home modifications and other related services; long interest lists. Disability Benefits Assistance 210.732.6078 814 West Euclid Ave, SA TX 78212 This program offers assistance and information for people with disabilities who are applying for benefits. Hill Country MHDD Centers 830.792.3300 Web: http://www.hillcountry.org 819 Water Street, Ste. 300, Kerrville, Texas 78028 Providing mental health, individual developmental disability, and substance abuse, services throughout the greater Texas Hill Country (Bandera, Blanco, Comal, Edwards, Gillespie, Hays, Kendall, Kerr, Kimble, Kinney, Llano, Mason, Medina, Menard, Real, Schleicher, Sutton, Uvalde, and Val Verde counties) Home and Community Based Services (HCS) 210.832.5020 8700 Tesoro Dr., Ste. 160, SA TX 78217 Intake application: Click Here About: Click here HCS is a Medicaid waiver program that supplies services and supports to Texans with an intellectual disability (ID) or a related condition so that they can live in the community. HCS services are intended to supplement rather than replace services received from other programs, such as Texas Health Steps, or from natural supports, including families, neighbors or community organizations. Social Security Disability Insurance (SSDI) 1.800.772.1213 Web: http://ssa.gov/ Social Security Disability Insurance (SSDI) is a federally run benefits program that provides aid to people who are unable to achieve gainful employment due to a permanent disabling condition. SSDI is financed by the Social Security tax. Therefore, any person that qualifies as disabled according to the definition provided by Social Security Administration (SSA); and who has paid Social Security taxes long enough to achieve sufficient work credits; can qualify for SSDI. Social Security Disability Insurance; also known as SSDI or SSD; provides income to individuals no longer able to work because of a physically or psychologically restrictive disability. SSDI is funded by payroll taxes and does not depend on the recipient’s income level; as it is based solely on work history and the degree of disability. Supplemental Security Income; or SSI; offers monetary assistance to low-income individuals who are at least age 65; blind; and/ or disabled. SSI pays cash benefits to supplement the cost of food; clothing; and shelter. Provides Medicaid coverage and monthly cash assistance to eligible individuals; eligibility is based on citizenship status, financial status and disability. TX Dept. Of Aging & Disability Services-Medically Dependent Children Program (MDCP) 1.877.438.5658 Web: Click Here The program provides services to support families caring for children and young adults who are medically dependent and assist with the transition of children in nursing homes. Services include: Adaptive aids; adjunct supports; minor home modifications; financial management services; respite services; transition assistance services and more. To qualify, applicants must have a child with a disability less than 21 years of age; be a U.S. Citizen or an alien with approved status who lives in Texas; be low income and eligible for Medicaid; must meet the medical necessity determination for nursing home care and cannot be currently enrolled in another waiver program. Call to get on the interest list. Previous Next

  • Alma Patricia del Angel, MD

    < Back Alma Patricia del Angel, MD Chief Medical Officer & Developmental Behavioral Pediatrician Dr. A Patricia Del Angel graduated from medical school at the Universidad Autonoma de Tamaulipas. She did her pediatric residency training at Lincoln Hospital and Mental Health Center/New York Medical College, where she also served as chief resident. In addition, she completed a fellowship in child development-behavioral pediatrics at King Drew Medical Center in Los Angeles, and received her specialist certification in infant mental health from the Early Childhood Center at Cedars Sinai in Los Angeles. Dr. Del Angel has most recently served as a pediatrician at People’s Clinic in Austin and as a developmental-behavioral specialist in the pediatric residency program at UTMB Austin. Previously, Dr. Del Angel was the clinical director of the Southwest Area Children’s Hub in Los Angeles for thirteen years. She is a fellow of the American Academy of Pediatrics. Dr. Del Angel is the proud aunt to two neurodivergent children. ap.delangel@acn-sa.org (210) 435-1000

  • Clinician Track: AM Breakout Session: The Movement Sensing Perspective UNPACKED | Acn Home

    Clinician Track: AM Breakout Session: The Movement Sensing Perspective UNPACKED Time 10:00-11:15 AM Presenter/Facilitator Rosemary White, OTR/L Back to Course List < Back Clinician Track: AM Breakout Session: The Movement Sensing Perspective UNPACKED In this presentation, Rosemary White, OTR/L brings clarity, depth, and clinical relevance to Elizabeth Torres’s groundbreaking Moving Sensing Perspective in autism. Drawing on her decades of experience in occupational therapy and neurodevelopmental work, Rosemary unpacks Torres’s rich, data driven research and translates complex concepts into practical understanding for clinicians supporting autistic children, adults, and their families. Rosemary bridges theory and practice by explaining how movement, sensation, and nervous system variability offer crucial insights into how autistic individuals experience and respond to the world. She reframes common clinical observations—such as differences in motor control, regulation, attention, and communication—through the lens of self-generated sensory feedback and lived physiological experience, moving beyond behavior-based interpretations. Throughout the talk, Rosemary emphasizes why this perspective matters for everyday clinical decision-making. She explores how understanding individual movement signatures can support more respectful assessment, reduce misinterpretation of intent, and guide interventions that prioritize regulation, safety, and autonomy rather than normalization or compliance. Case examples illustrate how this framework can deepen collaboration with families and empower clinicians to listen to what the body is communicating, not just what is observable on the surface. Learning Outcomes: Participants will analyze the Movement Sensing Perspective to explain how movement, sensation, and nervous system variability shape the lived experiences of autistic individuals. Participants will interpret clinical observations—such as motor differences, regulation, attention, and communication—through the lens of self-generated sensory feedback rather than behavior-based assumptions. Participants will apply movement-informed assessment and intervention strategies that prioritize regulation, safety, and autonomy while enhancing collaboration with families. Rosemary White, OTR/L is from Australia and has been an Occupational Therapist since 1972. Rosemary received her Neurodevelopmental Therapy training in London with the Bobaths, her Sensory Integrative Therapy training in Los Angeles with Dr. A Jean Ayres and her training in DIR®/Floortime with Stanley Greenspan, MD and Serena Wieder, PhD and the Faculty of ICDL. Rosemary is the owner of a private practice and specializes in working with children presenting with challenges relating and communicating such as autism, sensory processing/integration differences and motor planning and regulatory/attention differences Rosemary’s practice emphasizes understanding the impact of the child’s sensory processing and postural control on their capacity to relate, communicate and learn. Disclosure: Rosemary White, OTR/L is a paid speaker at ACN 2026 Summit- Toward Neuroharmony: Welcome to the Autism Renaissance.

  • 'Emergent and transactional': How Jonathan Green is Rethinking Autism and Interventions | Acn Home

    < Back 'Emergent and transactional': How Jonathan Green is Rethinking Autism and Interventions Brady Huggett Aug 28, 2023 Brady Huggett Hi, I am Brady Huggett, the enterprise editor at Spectrum. Recently, a paper was published in the journal Child and Adolescent Mental Health. The paper was written by Jonathan Green, a researcher and clinician at the University of Manchester at Royal Manchester Children's Hospital, and Manchester Academic Health Science Center, all in Manchester, U.K. The article is titled “Debate: Neurodiversity, autism and healthcare.” There have since been a few commentaries in response to Jonathan's article, and it has generated some online chatter, which is not unusual around these topics. So we wanted to talk with Jonathan about this paper, why he wrote it, what his key themes are, and also discuss the early reaction to it. That's what I've done. That's the focus of this interview. We talked on August 3rd, 2023, morning for me and, and mid-afternoon for Jonathan in Manchester. And before we get going, I'll say that if you are listening to this on a podcast app, on spectrumnews.org , the posting for this interview includes links to some of the papers that Jonathan and I discuss. So that's all you need to know. We'll start here, where I'm asking Jonathan how this paper came about. [transition music] All right. So, Jonathan, I think the first thing that we should talk about is your impetus for writing this paper. What were you thinking about and how'd you come up with this topic? Jonathan Green Yeah. Um, thanks, Brady. Um, I think the, uh, the occasion of writing the paper really came from the current, uh, very fluid, contentious, and often really difficult situation for clinicians, uh, with the current status of autism, debates around neurodiversity, etc. I was asked to write the paper, actually, after I delivered a lecture about the history of autism- history of the autism concept, and how I thought it had altered over time, and, uh, what I thought the current- uh, what I called the paradigm shift, uh, real, real turning, pivoting points now were, and-and they asked me to write this, uh, this contribution after that. I've worked as a clinician in this field for 30 years or so, and as also a clinical scientist. And I just know the complexity for, uh, clinicians in this field at the moment and the pressures they're under. So this is partly to-to help them. Brady Huggett Can I ask, you-you said you were asked to write the paper, that's by the journal, the journal asked you to write the paper? Jonathan Green Uh, yeah. That's exactly, yeah. Brady Huggett Yeah. OK. And I was gonna ask too, who-who you thought the audience was, and it's for clinicians. I mean, really you're trying to lay forth some new thoughts for clinicians here. Jonathan Green Yeah, I've- that-that's-that is the case, uh, Brady. I, um, I have written some other papers on this topic recent- the last couple of years, which have really been addressed as much or more to the, uh, broad scientific, uh, uh, professional audience, um, and also to the neurodiversity community, and of course, in this modern, uh, media age, you know, that I-I'm totally aware that what I wrote in this paper, although I had clinicians in mind, um, of course, other people will read it, and they have, and they've commented. So, uh, you know, that's-that's just normal these days. Brady Huggett So you, I think, most recently, you-you wrote on this topic in October of 2022. Jonathan Green Yeah. I wrote a-a paper called “Autism as, um, Emergent and Transactional,” um, which is- was a theory paper that really folds into this. And perhaps it would be useful just to explain the origin of these ideas, um, which really lay-lay behind the-the argument in the paper. So earlier in my, uh, career, I, uh, my, uh, my first, uh, area of, uh, research, developmental research actually was in individual different psychology, and particularly in temperamental variation in newborns and, uh, early infancy and its consequence. Uh, so I was, um, very much involved in the-the notion of individual difference and its consequences in development. And within that, the study of temperament historically, uh, I think was a very interesting paradigm where the downstream consequences of early individual difference, which was largely assumed to be genetic in origin, was, uh, plotted in longitudinal studies. And this notion, uh, arose of the so-called transactional relationship between individual difference in development and the world around the individual. So I was imbued in that and in the sort of intervention research that was done early on, which showed that actually, with the right kind of intervention early on, one could actually mitigate the downstream effects of early difference and improve, uh, downstream outcomes, but within this transactional context. So, long story short, around 2000, uh, the turn of the century, um, I began with colleagues to apply this idea to autism as a developmental difference. And basically, we showed in these programs really quite strikingly that actually, you could alter the transactional dynamics early on with autistic difference. And actually, uh, more strikingly than that because that had- that's pretty common knowledge in a lot of intervention procedures, but then actually this-this altered and improved downstream autism, uh, phenotype. So this was not done with high-functioning autism. This was done with kids who are largely, uh, minimally-- well, uh, or, uh, didn't have free speech and had reduced IQ. This underlay the paper I-I wrote in last year on, uh, “Autism as Emergent and Transactional.” And you can see how the logic came from that. That's-that's-that's the second bit. And the third bit that underlays this paper is my engagement with the neurodiversity community and autism advocates over the last five, six, seven years, which has been quite intensive. And I've really engaged them, uh, quite deeply in phenomenological work. And, uh, thinking about their own experience and understanding the-the neurodiversity community and advocacy movements and all of those three things together then led me to the kind of position that, um, I'm talking about in the-in the paper here. Brady Huggett And so it's- OK, those are the roots. And you've sort of applied this to our current moment, if you will. And I think early in the paper, you said that there is a receding horizon for the scientific goals around autism, which I thought was a really interesting way to say it. Can you sort of expand on what you mean by that idea, that this is a receding horizon? Jonathan Green That was-that was put sort of purposefully like that to just- I-I think, um- I mean one anecdote to-to exemplify it, when I first worked in autism seriously in the '90s, uh, I was part of the first large, uh, international autism genetics consortium, which was looking at molecular genetics and-and at a big population level and big data. And we started out, I mean, I was junior in the-in the consortium, but, uh, which was led by Michael Rutter at that time. But, you know, I realized that it started out with basically a modeling that there would be probably six genes of main effect that would actually determine autism. That's where it was at the time, around 1995, right? And what I've seen in that consortium, and we've seen over the- over the time, of course, is thatthat wasn't the case, that we've now got maybe 1,000 genes of sm- uh, of small effects, CNVs, plus of course, uh, uh, proportion like 14 percent or so of-of single-gene disorders of main effect that are associated with autism. So- but if you look at common familial autism, this is a polygenic condition. And, um, so there's a-a receding horizon on the genetic silver bullet, right? Which is what we started with. There's also a receding horizon on, um, biomarker identification, not only a genetic, but at a neuroscience level. So I've been involved in a lot of the early babysibs projects in terms of early neurodevelopmental studies. Bottom line, we haven't got a-a simple, um, uh, early marker, predictive marker for-for autism in that sense. I- so that's what I mean by a receding horizon, Brady, um, and the idea that, you know, which some, uh, people misunderstand, that a lot of genetic research basically implies eugenics i-is-is kind of scientifically nonsensical. We'll never find a-a gene, um, marker, a prenatal gene marker that would enable that. Brady Huggett Yeah. So that led you to write, I think that you called it an- right now we are- there's an unparalleled flux in our understanding of autism, right? Jonathan Green Yeah. Brady Huggett And-and as you said, 1994, everyone sort of thought they-they- we would figure it out, it'd be very simple. That's been not the case at all. And now we're sort of in this area where, um, it's not clear what might be known or what even isn't known yet. And that, I think is what led you to sort of say, "Now we need to think about treatment differently." Jonathan Green That's true. I mean, I don't wanna under-underestimate, uh, and under-respect the huge science work that's gone on and the amount we've learned from it, but I think what we've learned Brady Huggett Oh, sure. Jonathan Green What we've learned is complexity and Brady Huggett Yes. Yeah. Jonathan Green -uh, you know, we need to take a different paradigm view. And, uh, the other aspect of the paradigm shift is-is like what we-what we mean by autism. I mean, one of the sections in my paper was, “What is ‘autism’ anyway?” And, you know, and that's come under a lot of debate. And I do think that the advocacy movement has brought into play for us in the clinical science community vividly the lived experience of autism, and that- and the importance of that in our consideration. Brady Huggett OK. So, if we have this idea that autism now is, uh, emergent and transactional, and that's gonna lead hopefully to a new way to treat aspects of autism, I suppose. Take me through how that works and sort of what's needed to be uniformly believed, or not maybe not uniformly, collectively believed in order for that to work. And you-you've laid out three or four things that need to happen. Jonathan Green Yeah. I mean, what I suggest is-is that we need to have a more of a shared understanding that what we call autism is rather a dynamic entity. You know, when I first started in the field, there was this, like, quite preformist idea, really, that autism was a neurological, uh, disorder, uh, that emerged over time as sort of biological emergence. Um, and, uh, it was nothing you could do about it. Certainly, in the U.K., it was total therapeutic nihilism that you could do anything about this unfolding, right? Um, and I think we-we do need to change that. I think the work I've done in-in our therapy program and other people too have shown that no, this- there is, you know, within limits, there is, uh, work that one can do on the environmental aspects around autism that can really cha- substantially change things. So I think we need to do that. And, um, you know, I think we need to seriously realize that we can actually invest in really good early environmental adaptations right from the get-go that could make at least some difference to the evolution of the phenotype. And I've-I've suggested in the paper that, um, we really need to recast our intervention model to be much more proactive, more, um, preventative in orientation, uh, rather than reactive and firefighting, uh, which is so much of what goes on at the moment. Uh, but there's also the need, and this is another aspect of the paper, uh, we need to, uh, avoid culture wars around, um, you know, uh, fighting about what autism is and, um, which is a really unfortunate aspect at the moment. And-and so I wanted to try and create a kind of shared language, um, model that-that would be at least reasonably acceptable to, um, both the, um, the neurodiversity community and also to the, uh, community of, um, adults and parents whose, uh, whose children and adults who have major disability, you know, and no one is underestimate- certainly not me, since I've worked with them for 30 years, underestimating, uh, the-the importance of that and the need. So, uh, this, the idea that, you know, that intervention is-is-is inappropriate is-is not compatible with clinical experience. And there's- so there are real dilemmas here that we have to really, uh, talk about together. Brady Huggett Yeah. So the-the idea basically in this, you know, as you said, we're in this unparalleled flux of our understanding, is to maybe make a shift from, "Hey, we're looking for these genes so that we can affect these genes," to autism is emergent. How do we change the environment so that this autistic person, this autistic young child, flourishes so that their outcome is improved? Jonathan Green Yeah. That- in a- in a nutshell, that is exactly the paradigm, and it-it-it-it-it-its orientation is-is to, um, accept and value the difference, but to try and optimize the outcomes as much as one possibly can. And what we can do in health care, I think, is this early intervention piece, but of course, it links with societal change, uh, with change in the workplace and all sorts of other things that are beyond earlier education, that are beyond health care to actually within the same model of accommodation to improve flourishing and outcomes. Brady Huggett You just- you-you just mentioned, and you mentioned this in the paper, that there's been this sort of fracturing of the landscape. The neurodiversity movement has brought like, uh, just a ton of attention to things that were not being looked at before, honestly, and that- and that has bumped up against the medical community, which is sort of looking at autism as this medical condition, right? This is the social model versus the medical model that you-you alluded to before, and you're hoping the paper might sort of help stop the fracturing. Do you think it's been able to do that? I know it's early days, of course, the paper's not even out in print yet, but what is your thoughts about this after having been out for a while? Jonathan Green Uh, well, obviously, the paper in itself won't do it, but, um, I think that I am committed to a-a-a common language. I think, uh, as I- and I wrote about this a bit more extensively in the-the 2000-the 2022 paper on, uh, emergence and transaction that, you know, we have-- part of the whole remit of clinical science has been to integrate the basic biology, basic science, clinical practice, and-and social understanding, youyou know, to have a unified view is-is so powerful. And, um, so how are we gonna do that? Well, we do need a model, and that's what I'm trying to present here. We do need a model of thinking, but then of course, we need, um, dialogue, and we need engagement with each other. And, uh, I try and do as much of that as I can myself and others that are also doing it. And they'll need to be given on both sides. That's obvious, uh, because there is a, uh, a lot of incompatibility. You know, one thing I-I don't want my model to-to underplay is the, um, the disability aspects of a lot of autism and/or to overplay how much treatment can do. I think it can do a lot, and we've shown this empirically what it can do, but it-it's not a magic cure. And I think from the other side, there's-there's too much defensiveness about the-the felt threat from neurodiversity language, um, the social model and, uh, advocacy community. And, uh, and it-it sort of, uh, I mean there are de- there-there are trigger areas around which this revolves, of course. I mean, one is the notion that, um, any intervention or treatment is, uh, is basically destroying autism or under- or-or trying to wipe it out, uh, that sort of eugenics narrative, which is, you know, a-a tough one. And, um, when I'm in the room with autistic advocates and, uh, we can really talk this through, I-I think and hope that there's a- there can be a bit of mutual understanding here. And I hope that the kind of treatment model I'm proposing is more acceptable because this is not about changing or wiping out autism, it is about, uh, supporting it. You know, that's the argument we've made, and I think generally that's been understood and supported by- Brady Huggett Yeah. Jonathan Green -many. Brady Huggett Yeah. So, let-let me-let me ask about that 'cause I think-I think when- you tell me what-what feedback you've gotten on this paper already, but I think the idea would be for a neurodiverse advocate, if they-if they read this paper, they would say what they're doing is trying to lessen autistic traits and therefore make me less autistic, and that is what they're fighting against. Jonathan Green Well, yeah. This is-this is, uh, a complex, very nuanced, um, uh, argument here. I mean, it's-it's-it's so interesting because it comes up against autism identity. So, there's a social identity model and argument, but a lot of it gets tied to this behavioral phenotype definition diagnosis. Now, this is a complex argument because if people then say, "Well, no, you're- then you are taking away my autism identity," what I say is, no, I'm not, I'm-I'm really not doing that. But the-the nature of autism development is like all our developments, all our identity develops in over time. You know, none of it's pre-formed. None of us have a preformed identity, and I don't believe autism identity is preformed either. Um, you know, and so one has to-to take this developmental argument, but of course, in the social space, autism identity is a binary, and it's a valued identity. And so that is a very reala very real dialogue and challenge, a mutual challenge I-I'd say. But from a- I think what I'd be saying, and the- and this is where I think the phenomenology is important, is that we actually think from the phenomenology work that we've done that the-the core neurodivergent phenotype may lie slightly be-behind what the behavioral phenotype currently tells us, so that if you listen to autistic people and their experience, actually, their experience doesn't really map onto the DSM category. You know, their-their experience is of an overwhelming world, a huge sensitivity, which often has great benefits as well as difficulties associated with it, an attentional style, which is highly focused at times, and then, uh, feels pretty, uh, chaotic at other times, but again, has some very, uh, powerful strengths to it. And all of this, of course, is from the, um, verbal advocacy and this is often what's criticized about. It's not representative, but it-it's a very important group, and these people can tell us what it feels like to be autistic. And what they tell us doesn't map onto DSM very well. We may want to alter the phenotype a bit, which may in turn alter what people think of as the autistic identity. And it's not the same as the ADOS thing that we measure and that we change because what I'm a-arguing is that what we are changing is downstream effects, which is not quite- which is slightly different. So it's a-it's a subtle argument, but I hope that's clear. And one other thing I wanna say is that intellectual disability associated with autism is another big issue here. So that for children who are non- and-and adults who are non-communicative, who have- or nonspeaking, um, who-who are really cognitively, uh, delayed and autistic, what's their lived experience? Is that a very different kind of thing? And a lot of the time, we just don't know that because we haven't been creative enough in being able to access their experience. And I think that is a-an area that we're gonna need to really look at. Brady Huggett I-I wanted to ask a thing too because you-you mentioned- in the paper, you actually mentioned that you'd worked on another paper with three autistic colleagues of yours, and you sort of went back over your earlier lives and you realized there were some similarities in the way that, um, you developed versus the way they developed, and also some differences. But on this-on this paper, you're the only author, but did you run this past some of those same colleagues? Jonathan Green Uh, yes. Yes. The, um, uh-uh, these ideas have been, uh, talked about with them. I mean, I'm not- I'm not saying that they would agree with everything I've written here, but they're familiar with these, uh, with the model that I've put forward. And, um, I think I've learned a lot from them, which has also illuminated thethe model. So, uh, Jo Bervoets, who I, uh, reference in the article is one of those colleagues that I wrote that paper with. So, uh, I'm not- I'm not claiming they'd sign up to this, [chuckles] but, um, you know, that- I-I hope that this is something- my informal feedback is that this is, uh, something that's at least to-to some of those colleagues is-is an acceptable kind of way of framing the thing. Yeah. Brady Huggett Yeah. A couple of things I wanna ask you and then we're done, but one is, what feedback have you seen? Again, it's not out in print, but it is online, and as you said, it has been disseminated widely. What feedback have you seen? I mean, I have some- I have seen people online saying things like, "This is eugenics," as you mentioned, right? Um, what-what feedback have you gotten? Jonathan Green Uh, well, there are- there are a couple of, um, published commentaries on the paper. So the-the journal, uh, commissioned, uh, actually three commentaries, uh, but two are- two are in at the moment. Um, and so they're available, so you can see those. One is from a-an autistic, uh, advocate, uh, academic, and the other from a clinical science, uh, colleague. Um, so there, you'll see there- I mean the-the, um, if I distilled it down, the-the-the feedback from the clinical science colleague is largely, um, I-I would say supportive of the model. Uh, the-the autistic, uh, advocate, uh, colleague, particularly focused on a-a lack of, um, in this, what- in my paper, on a lack of attention to autistic identity. And I think she's right to do that. I don't think I have talked about that, uh-uh, very much. Uh, partly it's because I don't feel really qualified to do so. She makes some points that, you know, that-that there's not enough attention to that. And I, you know, I do accept that that is a-a legitimate area where we have to really wrestle and discuss together about those things 'cause there are some paradoxes in there. Otherwise, um, online, yeah, there's been, uh, some of the sort of Twitter commentary around eugenics, which is, you know, I think is a bit, um, it's like any-anything that in- that-that suggests intervention at this current time can provoke that, uh, kind of feedback. And I hope I've tried, really tried hard to, um, to explain why I think that this, the kind of intervention certainly, that we are talking about here, um, its-its aim is to- is to validate and to support, uh, neurodiversity rather than, uh, get rid of it. Um Brady Huggett Yeah. Jonathan Green -so Brady Huggett Yeah. Jonathan Green -uh, you know, you do what- one does one's best with that. Brady Huggett Yeah. So just the final question. You know, this-this paper mentions neurodiversity throughout, and the word has, I mean, grown exponentially since it was first coined. And I think, almost that everybody has their own definition of what that word means, and I'm wondering how you would define neurodiversity. Jonathan Green Um, yeah. So I-I don't think I would want to, um, hazard an overall definition because, as you say, this is a term that has been used so differently by different people. I mean, of course, it-it began as a-a-a term of, uh, assertion really, of the importance of um, you know, neurological differences. Um, and it-it-it came from the, you know, neurodiversity community, um, uh, as a-as a- an idea. And I think it really applies to the idea that there is a range of brain difference. Uh, and I suppose whatwhat is, um, controversial about it or-or radical about it, is how wide you take that net. You know, we-we could, you know, think about, um, dyslexia, dyspraxia, dyscalculia, you know, these things are all very, uh, you know, and they're not really pathologized as it were really within the developmental science. And then you- then you can think about ADHD, uh, another neurodevelopmental condition that is, as it were, "pathologized", intellectual disability, Tourette syndrome, anorexia, schizotypy. Uh, so it's, uh, how broad you-you embrace the differences here. So that's an important thing, is like there's a range of, as it were, normative variation. And it's how broad, and I think the neurodiversity community would often wanna argue for a very broad definition of-of-of this. So, uh, and then, of course, there's the idea that-that the concurrent with that is the-the fact that the people should have equal social rights, um, and, uh-uh, so as a sort of social activism. Um, you know, I think that then if you are- OK, so how do I respond? Well, basically the idea is in essence intuitive to me from, as I said, I started off with the idea of individual difference, um, uh, research. And a lot of this is just a reframing of that. Uh, you know, we know a lot of the genetics research has suggested there are a lot of common genetics, uh, between these different conditions. I'm personally more of a splitter than a lumper. So I like to keep, uh, these-these individual conditions, I think have very particular characteristics. And I don't wanna lump them all together into one thing, but there'sthere's-there's is clearly a family of neuro-neuro difference. [chuckles] So, yeah, I think, um, neurodiversity is quite an interesting concept, both scientifically in terms of shared genetics. Um, you know, and you maybe were, uh, familiar with the essence, uh, model of, uh, Chris Gillberg, which he's talked for many years about how all these conditions are all somewhat part of a one group. Um, and I've personally not really agreed with him, but, you know, it's there, that he's argued that for many years. And I don't think there's a big difference between that and a lot of what the advocacy community say from their own lived experience perspective, to be honest. And I think we can learn a lot from each other about that. Brady Huggett Uh, that was a- one of the longest definitions of neurodiversity I've ever heard, but-but a complex one. I like it, thank you. Thank you. Um, that's-that's all I had, Jonathan. Uh, thanks for taking the time to talk about your paper and Jonathan Green OK. Brady Huggett -uh, good luck with it. Jonathan Green Thank you. Previous Next

  • CASE MANAGEMENT & FAMILY SERVICES | Acn Home

    < Back CASE MANAGEMENT & FAMILY SERVICES About Case Management Services Our case management and family services resources provide information on support services available to individuals with autism and their families. These resources can help families navigate the often-complicated system of autism services and find the help they need. Also, inquire about our in-house autism case management resources! CASE MANAGEMENT & FAMILY SERVICES AACOG, Alamo Local Authority for IDD 210.830.5020 Web: www.aacog.com 8700 Tesoro Dr., Ste. 800, SA TX 78217 Provides Eligibility Determination (autism is a related condition), service coordination for General Revenue Services and Texas Home Living program, enrollment into the Home and Community-Based services program, In-Home Family Support Program and admissions into Intermediate Care Facilities-MR and State Schools Any Baby Can of San Antonio 210.227.0170 Web: www.anybabycansa.org 217 Howard St. San Antonio, TX 78212 Provides case management, to families who have a child aged from newborn to age of 17. Provides crisis assistance, referrals, small group counseling, individual counseling, financial assistance and parent education for children with autism. ARC of San Antonio 210.490.4300 Web: www.arc-sa.org 13430 West Ave. San Antonio, TX 78216 FAMILY SUPPORT SERVICES: Provides a social service “home” for families and caregivers of individuals with intellectual or other developmental disabilities. Support Service Coordinators will help families connect to programs and find resources. Eligibility: all ages, no income restrictions, serving Bexar County and surrounding communities. COMMUNITY SUPPORTS CASE MANAGEMENT PROGRAM (CSCM): Provides comprehensive case management services for families who have a child/young adult(s) with special health care needs. Eligibility: Ages 3-21 years. Non- Medicaid eligible. Bexar and surrounding counties. COMMUNITY LIVING ASSISTANCE & SUPPORT SERVICES (CLASS): Contact Yolanda Fuentes, Director of CLASS Case Management at yfuentes@arc-sa.org . Provides individuals with disabilities access to the resources they need to live and work as independently as possible in the community. Case Managers coordinate services including provider care, specialized therapies, adaptive aids, minor home modifications and respite care. Eligibility: Must be actively enrolled in the CLASS Medicaid Waiver Program. Center for Healthcare Services - CHCS-ECI, formerly PACES 210.261.3300 Web: www.chcsbc.org 5802 S. Presa, San Antonio, TX 78223 O ff ering a variety of services for parents with children under the age of 3, who are experiencing developmental delays. Services include case management, family centered services, activities in familiar settings, and more. Mo family is turned away because they cannot a ff ord to pay. Free services for children on Medicaid. Other services provided based on family size and adjusted income. Previous Next

  • LOCAL Closer Look: Autism Community Network | Acn Home

    < Back LOCAL Closer Look: Autism Community Network Felipe Aguilar Feb 4, 2024 Felipe Aguilar talks with Adrienne Gaither, Director of Caregiver Empowerment and Occupational Therapist, Autism Community Network (ACN) in San Antonio. Gaither provides a historical and organizational overview of ACN. She also describes ACN’s mission as it applies to providing care to persons with Autism. Gaither gives some practical guidelines for caregivers of children with Autism and talks about the importance of early diagnosis. She describes services and resources that ACN provides to children and adults with Autism diagnosis. Learn more at ( https://www.acn-sa.org ). Listen to the interview here: https://www.klove.com/news/closer-look/hot-topx/local-closer-look-autism-community-network-san-antonio-7191 Previous Next

bottom of page